Ramya Chandrasekaran is a highly accomplished scientist with extensive experience in immunology and antibody discovery, currently serving as Principal Scientist for ADC Biology at Immunome, Inc. since November 2023. Prior to this role, Ramya held several positions at OncoResponse from November 2019 to October 2023, focusing on antibody and target discovery in immuno-oncology. Ramya's background includes critical research at Seattle Children's and Vanderbilt University, contributing to significant findings in host-pathogen interactions and vaccine efficacy. With a Ph.D. in Microbiology and Immunology from Vanderbilt University and a M.S. in Microbial Engineering from the University of Minnesota, Ramya possesses robust skills in project management, strategy planning, and a range of advanced immunological techniques. Numerous publications and a history of mentoring junior scientists underline Ramya's commitment to scientific advancement and collaboration in the biomedical field.
This person is not in any offices
Immunome
2 followers
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system.